StonvexLoading…
StonvexStonvexStonvexCore line items from CTEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $244.68M | $965.41M | $718.86M | $472.90M |
Operating Income | $6.64M | $28.77M | $36.39M | $26.32M |
Net Income | $-73.56M | $-284.28M | $-203.71M | $-133.96M |
EPS (Diluted) | $-4.41 | $-17.30 | $-12.42 | $-8.19 |
Total Assets | $4.84B | $4.89B | $4.99B | $5.07B |
Total Liabilities | $5.07B | $5.06B | $5.09B | $5.11B |
Cash & Equivalents | $21.33M | $16.81M | $39.15M | $56.39M |
Free Cash Flow OCF − CapEx | $-92.55M | $-12.28M | $-48.65M | $-32.31M |
Shares Outstanding | 17.00M | 16.55M | 16.51M | 16.47M |